cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Enochian Biosciences Inc
5 own
3 watching
Current Price
$1.19
$0.07
(6.25%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
62.83M
52-Week High
52-Week High
9.2299
52-Week Low
52-Week Low
0.9486
Average Volume
Average Volume
0.04M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization62.83M
icon52-Week High9.2299
icon52-Week Low0.9486
iconAverage Volume0.04M
iconDividend Yield--
iconP/E Ratio--
What does the Enochian Biosciences Inc do?
Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company s lead candidate includes ENOB-HV-01 for autologous HIV curative treatment; ENOB-HV-11, a preventative HIV vaccine; ENOB-HV-12, a therapeutic HIV vaccine; and ENOB-HB-01, a coopting HBV polymerase. Its pipeline development products comprise ENOB-DC-11 off the shelf DC vaccine for multiple solid tumors; and ENOB-DC-21, a non-specific vaccine for intraturmoral injection. Enochian Biosciences, Inc. has strategic partnerships with The Scripps Institute, Fred Hutchinson Cancer Research Center, the Texas Biomedical Research Institute, the University of California, Los Angeles, and The Hepatitis B Foundation and Baruch S. Blumberg Institute. The company was incorporated in 2017 and is headquartered in Los Angeles, California.
Read More
How much money does Enochian Biosciences Inc make?
News & Events about Enochian Biosciences Inc.
Globe Newswire
3 months ago
Initial, Pre-Clinical Animal Study Results Show Potential To Effectively Treat Pancreatic CancerLOS ANGELES, Oct. 17, 2022 (GLOBE NEWSWIRE) -- Today, Enochian BioSciences (the Company) announced that it was awarded a U.S. patent for its proprietary cancer treatment platform that could potentially be...
Globe Newswire
4 months ago
NEW YORK, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Enochian Biosciences, Inc. (NASDAQ: ENOB), Weber, Inc. (NYSE: WEBR), Coinbase Global, ...
Globe Newswire
4 months ago
LOS ANGELES, Sept. 26, 2022 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. ...
PR Newswire
4 months ago
FINAL DEADLINE ALERT: The Schall Law Firm Encourages Investors in Enochian Biosciences, Inc. with Losses of $100,000 to Contact the Firm FINAL DEADLINE ALERT: The Schall Law Firm Encourages Investors in Enochian Biosciences, Inc. with Losses of $100,000 to Contact the Firm PR Newswire LOS ANGELES...
Business Wire
4 months ago
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Enochian Biosciences, Inc. (Enochian or the Company) (NASDAQ: ENOB) in the United States District Court for the Central District of...
Frequently Asked Questions
Frequently Asked Questions
What is Enochian Biosciences Inc share price today?
plus_minus_icon
Can Indians buy Enochian Biosciences Inc shares?
plus_minus_icon
How can I buy Enochian Biosciences Inc shares from India?
plus_minus_icon
Can Fractional shares of Enochian Biosciences Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Enochian Biosciences Inc stocks?
plus_minus_icon
What is today’s traded volume of Enochian Biosciences Inc?
plus_minus_icon
What is today’s market capitalisation of Enochian Biosciences Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Enochian Biosciences Inc?
plus_minus_icon
What percentage is Enochian Biosciences Inc down from its 52-Week High?
plus_minus_icon
What percentage is Enochian Biosciences Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$1.19
$0.07
(6.25%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00